Global Radiopharmaceuticals Sales Market Report 2021

Name: Global Radiopharmaceuticals Sales Market
Brand: Stats And Research
SKU: Healthcare
Price: 2800 USD
Availability: InStock
Rating: 4.2 (20 reviews)

Published Date : 09-07-2021
Pages : 110
Report Id : 13140
Categories : Healthcare

This report studies the global Radiopharmaceuticals market status and forecast, categorizes the global Radiopharmaceuticals market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
In the last several years, global market of Radiopharmaceuticals developed year by year, with an average growth rate of 8.02% for the sales. In 2016, global revenue of Radiopharmaceuticals is nearly 4546 M USD; the sale is about 130 M Dose.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The proportion of Diagnostic Radioisotopes in 2016 is about 89.22%, and the proportion is in decreasing trend from 2012 to 2020. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 62.63%.
The global Radiopharmaceuticals market is valued at 4900 million US$ in 2020 and will reach 8410 million US$ by the end of 2027, growing at a CAGR of 8.0% during 2021-2027.

The major players covered in this report
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
United States
Europe
China
Japan
Southeast Asia
India

We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Diagnostic Radioisotopes
Therapeutic Radioisotopes
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
Oncology
Cardiology
Other

The study objectives of this report are:
To analyze and study the global Radiopharmaceuticals sales, value, status (2016-2020) and forecast (2021-2027);
To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
Focuses on the key Radiopharmaceuticals players, to study the sales, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Radiopharmaceuticals are as follows:
History Year: 2016-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2027

For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders
Radiopharmaceuticals Manufacturers
Radiopharmaceuticals Distributors/Traders/Wholesalers
Radiopharmaceuticals Subcomponent Manufacturers
Industry Association
Downstream Vendors

Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Radiopharmaceuticals market, by end-use.
Detailed analysis and profiles of additional market players.
End of Summary

Table of Contents

Global Radiopharmaceuticals Sales Market Report 2021
1 Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of Radiopharmaceuticals
1.2 Classification of Radiopharmaceuticals by Product Category
1.2.1 Global Radiopharmaceuticals Market Size (Sales) Comparison by Type (2016 - 2027)
1.2.2 Global Radiopharmaceuticals Market Size (Sales) Market Share by Type (Product Category) in 2020
1.2.3 Diagnostic Radioisotopes
1.2.4 Therapeutic Radioisotopes
1.3 Global Radiopharmaceuticals Market by Application/End Users
1.3.1 Global Radiopharmaceuticals Sales (Volume) and Market Share Comparison by Application (2016 - 2027)
1.3.1 Oncology
1.3.2 Cardiology
1.3.3 Other
1.4 Global Radiopharmaceuticals Market by Region
1.4.1 Global Radiopharmaceuticals Market Size (Value) Comparison by Region (2016 - 2027)
1.4.2 United States Radiopharmaceuticals Status and Prospect (2016 - 2027)
1.4.3 Europe Radiopharmaceuticals Status and Prospect (2016 - 2027)
1.4.4 China Radiopharmaceuticals Status and Prospect (2016 - 2027)
1.4.5 Japan Radiopharmaceuticals Status and Prospect (2016 - 2027)
1.4.6 Southeast Asia Radiopharmaceuticals Status and Prospect (2016 - 2027)
1.4.7 India Radiopharmaceuticals Status and Prospect (2016 - 2027)
1.5 Global Market Size (Value and Volume) of Radiopharmaceuticals (2016 - 2027)
1.5.1 Global Radiopharmaceuticals Sales and Growth Rate (2016 - 2027)
1.5.2 Global Radiopharmaceuticals Revenue and Growth Rate (2016 - 2027)

2 Global Radiopharmaceuticals Competition by Players/Suppliers, Type and Application
2.1 Global Radiopharmaceuticals Market Competition by Players/Suppliers
2.1.1 Global Radiopharmaceuticals Sales and Market Share of Key Players/Suppliers (2016 - 2021)
2.1.2 Global Radiopharmaceuticals Revenue and Share by Players/Suppliers (2016 - 2021)
2.2 Global Radiopharmaceuticals (Volume and Value) by Type
2.2.1 Global Radiopharmaceuticals Sales and Market Share by Type (2016 - 2021)
2.2.2 Global Radiopharmaceuticals Revenue and Market Share by Type (2016 - 2021)
2.3 Global Radiopharmaceuticals (Volume and Value) by Region
2.3.1 Global Radiopharmaceuticals Sales and Market Share by Region (2016 - 2021)
2.3.2 Global Radiopharmaceuticals Revenue and Market Share by Region (2016 - 2021)
2.4 Global Radiopharmaceuticals (Volume) by Application

3 United States Radiopharmaceuticals (Volume, Value and Sales Price)
3.1 United States Radiopharmaceuticals Sales and Value (2016 - 2021)
3.1.1 United States Radiopharmaceuticals Sales and Growth Rate (2016 - 2021)
3.1.2 United States Radiopharmaceuticals Revenue and Growth Rate (2016 - 2021)
3.1.3 United States Radiopharmaceuticals Sales Price Trend (2016 - 2021)
3.2 United States Radiopharmaceuticals Sales Volume and Market Share by Players (2016 - 2021)
3.3 United States Radiopharmaceuticals Sales Volume and Market Share by Type (2016 - 2021)
3.4 United States Radiopharmaceuticals Sales Volume and Market Share by Application (2016 - 2021)

4 Europe Radiopharmaceuticals (Volume, Value and Sales Price)
4.1 Europe Radiopharmaceuticals Sales and Value (2016 - 2021)
4.1.1 Europe Radiopharmaceuticals Sales and Growth Rate (2016 - 2021)
4.1.2 Europe Radiopharmaceuticals Revenue and Growth Rate (2016 - 2021)
4.1.3 Europe Radiopharmaceuticals Sales Price Trend (2016 - 2021)
4.2 Europe Radiopharmaceuticals Sales Volume and Market Share by Players (2016 - 2021)
4.3 Europe Radiopharmaceuticals Sales Volume and Market Share by Type (2016 - 2021)
4.4 Europe Radiopharmaceuticals Sales Volume and Market Share by Application (2016 - 2021)

5 China Radiopharmaceuticals (Volume, Value and Sales Price)
5.1 China Radiopharmaceuticals Sales and Value (2016 - 2021)
5.1.1 China Radiopharmaceuticals Sales and Growth Rate (2016 - 2021)
5.1.2 China Radiopharmaceuticals Revenue and Growth Rate (2016 - 2021)
5.1.3 China Radiopharmaceuticals Sales Price Trend (2016 - 2021)
5.2 China Radiopharmaceuticals Sales Volume and Market Share by Players (2016 - 2021)
5.3 China Radiopharmaceuticals Sales Volume and Market Share by Type (2016 - 2021)
5.4 China Radiopharmaceuticals Sales Volume and Market Share by Application (2016 - 2021)

6 Japan Radiopharmaceuticals (Volume, Value and Sales Price)
6.1 Japan Radiopharmaceuticals Sales and Value (2016 - 2021)
6.1.1 Japan Radiopharmaceuticals Sales and Growth Rate (2016 - 2021)
6.1.2 Japan Radiopharmaceuticals Revenue and Growth Rate (2016 - 2021)
6.1.3 Japan Radiopharmaceuticals Sales Price Trend (2016 - 2021)
6.2 Japan Radiopharmaceuticals Sales Volume and Market Share by Players (2016 - 2021)
6.3 Japan Radiopharmaceuticals Sales Volume and Market Share by Type (2016 - 2021)
6.4 Japan Radiopharmaceuticals Sales Volume and Market Share by Application (2016 - 2021)

7 Southeast Asia Radiopharmaceuticals (Volume, Value and Sales Price)
7.1 Southeast Asia Radiopharmaceuticals Sales and Value (2016 - 2021)
7.1.1 Southeast Asia Radiopharmaceuticals Sales and Growth Rate (2016 - 2021)
7.1.2 Southeast Asia Radiopharmaceuticals Revenue and Growth Rate (2016 - 2021)
7.1.3 Southeast Asia Radiopharmaceuticals Sales Price Trend (2016 - 2021)
7.2 Southeast Asia Radiopharmaceuticals Sales Volume and Market Share by Players (2016 - 2021)
7.3 Southeast Asia Radiopharmaceuticals Sales Volume and Market Share by Type (2016 - 2021)
7.4 Southeast Asia Radiopharmaceuticals Sales Volume and Market Share by Application (2016 - 2021)

8 India Radiopharmaceuticals (Volume, Value and Sales Price)
8.1 India Radiopharmaceuticals Sales and Value (2016 - 2021)
8.1.1 India Radiopharmaceuticals Sales and Growth Rate (2016 - 2021)
8.1.2 India Radiopharmaceuticals Revenue and Growth Rate (2016 - 2021)
8.1.3 India Radiopharmaceuticals Sales Price Trend (2016 - 2021)
8.2 India Radiopharmaceuticals Sales Volume and Market Share by Players (2016 - 2021)
8.3 India Radiopharmaceuticals Sales Volume and Market Share by Type (2016 - 2021)
8.4 India Radiopharmaceuticals Sales Volume and Market Share by Application (2016 - 2021)

9 Global Radiopharmaceuticals Players/Suppliers Profiles and Sales Data
9.1 Bracco Imaging
9.1.1 Company Basic Information, Manufacturing Base and Competitors
9.1.2 Radiopharmaceuticals Product Category, Application and Specification
9.1.2.1 Product A
9.1.2.2 Product B
9.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.1.4 Main Business/Business Overview
9.2 Bayer
9.2.1 Company Basic Information, Manufacturing Base and Competitors
9.2.2 Radiopharmaceuticals Product Category, Application and Specification
9.2.2.1 Product A
9.2.2.2 Product B
9.2.3 Bayer Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.2.4 Main Business/Business Overview
9.3 Mallinckrodt
9.3.1 Company Basic Information, Manufacturing Base and Competitors
9.3.2 Radiopharmaceuticals Product Category, Application and Specification
9.3.2.1 Product A
9.3.2.2 Product B
9.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.3.4 Main Business/Business Overview
9.4 Nordion
9.4.1 Company Basic Information, Manufacturing Base and Competitors
9.4.2 Radiopharmaceuticals Product Category, Application and Specification
9.4.2.1 Product A
9.4.2.2 Product B
9.4.3 Nordion Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.4.4 Main Business/Business Overview
9.5 Triad Isotopes
9.5.1 Company Basic Information, Manufacturing Base and Competitors
9.5.2 Radiopharmaceuticals Product Category, Application and Specification
9.5.2.1 Product A
9.5.2.2 Product B
9.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.5.4 Main Business/Business Overview
9.6 Lantheus
9.6.1 Company Basic Information, Manufacturing Base and Competitors
9.6.2 Radiopharmaceuticals Product Category, Application and Specification
9.6.2.1 Product A
9.6.2.2 Product B
9.6.3 Lantheus Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.6.4 Main Business/Business Overview
9.7 IBA Group
9.7.1 Company Basic Information, Manufacturing Base and Competitors
9.7.2 Radiopharmaceuticals Product Category, Application and Specification
9.7.2.1 Product A
9.7.2.2 Product B
9.7.3 IBA Group Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.7.4 Main Business/Business Overview
9.8 GE Healthcare
9.8.1 Company Basic Information, Manufacturing Base and Competitors
9.8.2 Radiopharmaceuticals Product Category, Application and Specification
9.8.2.1 Product A
9.8.2.2 Product B
9.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.8.4 Main Business/Business Overview
9.9 China Isotope & Radiation
9.9.1 Company Basic Information, Manufacturing Base and Competitors
9.9.2 Radiopharmaceuticals Product Category, Application and Specification
9.9.2.1 Product A
9.9.2.2 Product B
9.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.9.4 Main Business/Business Overview
9.10 Jubilant Pharma
9.10.1 Company Basic Information, Manufacturing Base and Competitors
9.10.2 Radiopharmaceuticals Product Category, Application and Specification
9.10.2.1 Product A
9.10.2.2 Product B
9.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2016 - 2021)
9.10.4 Main Business/Business Overview
9.11 Eli Lilly
9.12 Advanced Accelerator Applications
9.13 SIEMENS
9.14 Dongcheng
9.15 Navidea

10 Radiopharmaceuticals Maufacturing Cost Analysis
10.1 Radiopharmaceuticals Key Raw Materials Analysis
10.1.1 Key Raw Materials
10.1.2 Price Trend of Key Raw Materials
10.1.3 Key Suppliers of Raw Materials
10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
10.2.1 Raw Materials
10.2.2 Labor Cost
10.2.3 Manufacturing Process Analysis of Radiopharmaceuticals
10.3 Manufacturing Process Analysis of Radiopharmaceuticals

11 Industrial Chain, Sourcing Strategy and Downstream Buyers
11.1 Radiopharmaceuticals Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Radiopharmaceuticals Major Manufacturers in 2020
11.4 Downstream Buyers

12 Marketing Strategy Analysis, Distributors/Traders
12.1 Marketing Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
12.2.1 Pricing Strategy
12.2.2 Brand Strategy
12.2.3 Target Client
12.3 Distributors/Traders List

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes Threat
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 Global Radiopharmaceuticals Market Forecast (2021 - 2027)
14.1 Global Radiopharmaceuticals Sales Volume, Revenue and Price Forecast (2021 - 2027)
14.1.1 Global Radiopharmaceuticals Sales Volume and Growth Rate Forecast (2021 - 2027)
14.1.2 Global Radiopharmaceuticals Revenue and Growth Rate Forecast (2021 - 2027)
14.1.3 Global Radiopharmaceuticals Price and Trend Forecast (2021 - 2027)
14.2 Global Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast by Region (2021 - 2027)
14.2.1 Global Radiopharmaceuticals Sales Volume and Growth Rate Forecast by Regions (2021 - 2027)
14.2.2 Global Radiopharmaceuticals Revenue and Growth Rate Forecast by Regions (2021 - 2027)
14.2.3 United States Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2021 - 2027)
14.2.4 Europe Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2021 - 2027)
14.2.5 China Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2021 - 2027)
14.2.6 Japan Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2021 - 2027)
14.2.7 Southeast Asia Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2021 - 2027)
14.2.8 India Radiopharmaceuticals Sales Volume, Revenue and Growth Rate Forecast (2021 - 2027)
14.3 Global Radiopharmaceuticals Sales Volume, Revenue and Price Forecast by Type (2021 - 2027)
14.3.1 Global Radiopharmaceuticals Sales Forecast by Type (2021 - 2027)
14.3.2 Global Radiopharmaceuticals Revenue Forecast by Type (2021 - 2027)
14.3.3 Global Radiopharmaceuticals Price Forecast by Type (2021 - 2027)
14.4 Global Radiopharmaceuticals Sales Volume Forecast by Application (2021 - 2027)

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Disclaimer
List of Tables and Figures

Figure Product Picture of Radiopharmaceuticals
Figure Global Radiopharmaceuticals Sales Volume Comparison (K Dose) by Type (2016 - 2027)
Figure Global Radiopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2020
Figure Diagnostic Radioisotopes Product Picture
Figure Therapeutic Radioisotopes Product Picture
Figure Global Radiopharmaceuticals Sales Comparison (K Dose) by Application (2016 - 2027)
Figure Global Sales Market Share of Radiopharmaceuticals by Application in 2020
Figure Oncology Examples
Table Key Downstream Customer in Oncology
Figure Cardiology Examples
Table Key Downstream Customer in Cardiology
Figure Other Examples
Table Key Downstream Customer in Other
Figure Global Radiopharmaceuticals Market Size (Million USD) by Regions (2016 - 2027)
Figure United States Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Europe Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure China Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Japan Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Southeast Asia Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure India Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Global Radiopharmaceuticals Sales Volume (K Dose) and Growth Rate (2016 - 2027)
Figure Global Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2016 - 2027)
Figure Global Market Major Players Radiopharmaceuticals Sales Volume (K Dose) (2016 - 2021)
Table Global Radiopharmaceuticals Sales (K Dose) of Key Players/Suppliers (2016 - 2021)
Table Global Radiopharmaceuticals Sales Share by Players/Suppliers (2016 - 2021)
Figure 2020 Radiopharmaceuticals Sales Share by Players/Suppliers
Figure 2020 Radiopharmaceuticals Sales Share by Players/Suppliers
Figure Global Radiopharmaceuticals Revenue (Million USD) by Players/Suppliers (2016 - 2021)
Table Global Radiopharmaceuticals Revenue (Million USD) by Players/Suppliers (2016 - 2021)
Table Global Radiopharmaceuticals Revenue Share by Players/Suppliers (2016 - 2021)
Table 2020 Global Radiopharmaceuticals Revenue Share by Players
Table 2020 Global Radiopharmaceuticals Revenue Share by Players
Table Global Radiopharmaceuticals Sales (K Dose) and Market Share by Type (2016 - 2021)
Table Global Radiopharmaceuticals Sales Share (K Dose) by Type (2016 - 2021)
Figure Sales Market Share of Radiopharmaceuticals by Type (2016 - 2021)
Figure Global Radiopharmaceuticals Sales Growth Rate by Type (2016 - 2021)
Table Global Radiopharmaceuticals Revenue (Million USD) and Market Share by Type (2016 - 2021)
Table Global Radiopharmaceuticals Revenue Share by Type (2016 - 2021)
Figure Revenue Market Share of Radiopharmaceuticals by Type (2016 - 2021)
Figure Global Radiopharmaceuticals Revenue Growth Rate by Type (2016 - 2021)
Table Global Radiopharmaceuticals Sales Volume (K Dose) and Market Share by Region (2016 - 2021)
Table Global Radiopharmaceuticals Sales Share by Region (2016 - 2021)
Figure Sales Market Share of Radiopharmaceuticals by Region (2016 - 2021)
Figure Global Radiopharmaceuticals Sales Growth Rate by Region in 2020
Table Global Radiopharmaceuticals Revenue (Million USD) and Market Share by Region (2016 - 2021)
Table Global Radiopharmaceuticals Revenue Share (%) by Region (2016 - 2021)
Figure Revenue Market Share of Radiopharmaceuticals by Region (2016 - 2021)
Figure Global Radiopharmaceuticals Revenue Growth Rate by Region in 2020
Table Global Radiopharmaceuticals Revenue (Million USD) and Market Share by Region (2016 - 2021)
Table Global Radiopharmaceuticals Revenue Share (%) by Region (2016 - 2021)
Figure Revenue Market Share of Radiopharmaceuticals by Region (2016 - 2021)
Figure Global Radiopharmaceuticals Revenue Market Share by Region in 2020
Table Global Radiopharmaceuticals Sales Volume (K Dose) and Market Share by Application (2016 - 2021)
Table Global Radiopharmaceuticals Sales Share (%) by Application (2016 - 2021)
Figure Sales Market Share of Radiopharmaceuticals by Application (2016 - 2021)
Figure Global Radiopharmaceuticals Sales Market Share by Application (2016 - 2021)
Figure United States Radiopharmaceuticals Sales (K Dose) and Growth Rate (2016 - 2021)
Figure United States Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2016 - 2021)
Figure United States Radiopharmaceuticals Sales Price (USD/Dose) Trend (2016 - 2021)
Table United States Radiopharmaceuticals Sales Volume (K Dose) by Players (2016 - 2021)
Table United States Radiopharmaceuticals Sales Volume Market Share by Players (2016 - 2021)
Figure United States Radiopharmaceuticals Sales Volume Market Share by Players in 2020
Table United States Radiopharmaceuticals Sales Volume (K Dose) by Type (2016 - 2021)
Table United States Radiopharmaceuticals Sales Volume Market Share by Type (2016 - 2021)
Figure United States Radiopharmaceuticals Sales Volume Market Share by Type in 2020
Table United States Radiopharmaceuticals Sales Volume (K Dose) by Application (2016 - 2021)
Table United States Radiopharmaceuticals Sales Volume Market Share by Application (2016 - 2021)
Figure United States Radiopharmaceuticals Sales Volume Market Share by Application in 2020
Figure Europe Radiopharmaceuticals Sales (K Dose) and Growth Rate (2016 - 2021)
Figure Europe Radiopharmaceuticals Revenue (Million USD) and Growth Rate (2016 - 2021)
Figure Europe Radiopharmaceuticals Sales Price (USD/Dose) Trend (2016 - 2021)
Table Europe Radiopharmaceuticals Sales Volume (K Dose) by Players (2016 - 2021)
Table Europe Radiopharmaceuticals Sales Volume Market Share by Players (2016 - 2021)
Figure Europe Radiopharmaceuticals Sales Volume Market Share by Players in 2020
Table Europe Radiopharmaceuticals Sales Volume (K Dose) by Type (2016 - 2021)
Table Europe Radiopharmaceuticals Sales Volume Market Share by T

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Immediate acquisition

Your strategic edge begins with Stats and Research

Single User License

$2800

It allows one person, the buyer, to have sole right and access to the purchased report. Further distribution of product is strictly prohibited.

Multi User License

$3800

It allows the purchased product to be shared among 1-5 employees of your organization within same geographical location.

Enterprise User License

$4800

It allows the purchased product to be shared among all employees of your organisation irrespective of their geographical location.

Services

View All Healthcare Reports

Global Cellular Products Market

Global Blue Light Therapy Device Market

Global Artificial Intelligence Based Blood Test Market

Global Digital Pills Market

Global POC Ultrasound Market

Global Needle-Free Blood Testing Market

Global Medical Tourism Market

Gummy Supplements Market

Software As a Medical Device (SaMD) Market

Canada Consumer Healthcare Market